Copyright: ©Author(s) 2026.
World J Gastroenterol. Aug 7, 2026; 32(29): 119809
Published online Aug 7, 2026. doi: 10.3748/wjg.119809
Published online Aug 7, 2026. doi: 10.3748/wjg.119809
Figure 2 Progression-free survival nomogram.
RECIST: Response Evaluation Criteria in Solid Tumors; TRG: Tumor regression grade; PFS: Progression-free survival; cTNM: Clinical tumor-node-metastasis.
- Citation: Zhou DX, Jiang SW, Zhang CG, Cai BJ, Lv HD. Perioperative SOX plus sintilimab vs P-SOX and CAPOX in advanced gastric cancer: A real-world comparison. World J Gastroenterol 2026; 32(29): 119809
- URL: https://www.wjgnet.com/1007-9327/full/v32/i29/119809.htm
- DOI: https://dx.doi.org/10.3748/wjg.119809